Menopause is a single point in time, and what it sets in motion continues for the rest of your life. Some of what happens passes on its own. Some of it does not, and knowing which is which is most of what matters.
Reviewed by Allison Mollet, PA-C, MSCP
Updated August 2026
Menopause is the point twelve months after your final period. It is identified looking backward, there is no test that announces it on the day, and the average age in the United States is 52.
Everything before it is perimenopause, the transition. Everything after it is postmenopause, which is most of the rest of your life.
Three variations matter clinically. Early menopause is menopause between 40 and 45. Premature ovarian insufficiency is menopause before 40, and it is a distinct diagnosis with its own workup. Surgical menopause, the removal of both ovaries, is more abrupt and typically brings more intense symptoms, because there is no period of adjustment.
Estradiol, progesterone and testosterone act on tissue almost everywhere: brain, bone, blood vessels, skin, bladder, vagina, muscle.
A woman's body runs on them for forty years.
During perimenopause estrogen fluctuates, sometimes to levels higher than in her twenties. That instability is what makes the transition so erratic and so hard to identify.
After menopause the instability ends. Estrogen settles at a low level and stays there. Progesterone production essentially stops, because it depended on ovulation. Testosterone continues the gradual decline it began in her twenties.
This is why postmenopause feels different from perimenopause rather than simply more so. The symptoms that came from the swings tend to settle. The ones that come from the low level do not.
This is the distinction worth carrying into any decision about treatment.
Hot flashes, night sweats, disrupted sleep, mood and concentration. These are miserable and they are temporary. They usually improve over a period of years, though "years" can mean many, and they last longer on average in Black and Hispanic women. Treating them is a decision about how you want to spend the years in question.
Vaginal and urinary tissue, bone, and cardiovascular risk. These do not resolve. They progress, and they do it without producing symptoms until something goes wrong.
The first group is about how you feel now. The second is about the next thirty years.
That the first group is self-limiting is not an argument for waiting it out. It only means the cost of waiting is measured in years of feeling badly rather than in permanent change. In the second group, the cost of waiting is the change itself.
The useful distinction is between what passes and what does not. We treat the first because a woman should not have to endure it, and the second because it will not improve on its own. Most women arrive having been told this is normal aging. It is, and that is not the same as untreatable.
— Allison Mollet, PA-C, MSCP
Hot flashes and night sweats affect most women through the transition and the years after it. They tend to be most frequent in late perimenopause and the first years after the final period.
Duration varies, and it varies by ethnicity: Black and Hispanic women experience them for more years on average than white and Asian women (National Institute on Aging).
Sleep disruption often improves alongside the night sweats, though not always. Poor sleep drives much of the fatigue, irritability and difficulty concentrating that gets attributed directly to hormones.
Mood and cognitive symptoms are most pronounced during the transition itself and generally improve after menopause rather than continuing to worsen.
Genitourinary syndrome of menopause is the term for what low estrogen does to vaginal and urinary tissue: dryness, thinning, discomfort or pain with sex, urinary urgency, and more frequent urinary infections.
Unlike hot flashes it is progressive. It does not resolve, and it worsens with each year it goes untreated.
It is also the symptom women are least likely to raise and least likely to be asked about, which is why it goes untreated far more often than it should. It responds well to treatment, including years after menopause.
Bone. Bone loss accelerates in late perimenopause and the years immediately after the final period. It produces no symptoms until a fracture, which is why it is worth measuring rather than waiting for.
Cardiovascular and metabolic. Cholesterol, blood pressure, body composition and insulin sensitivity all shift after menopause, and cardiovascular risk rises accordingly. These also produce no symptoms in the early years.
Hormone therapy is the most effective treatment for hot flashes and night sweats, and it addresses sleep, mood, genitourinary symptoms and bone at the same time. Whether it suits a particular woman depends on her history and where she is relative to menopause. Our *benefits of hormone therapy* page makes the case.
Estrogen and progesterone are the core. A woman with a uterus needs progesterone alongside estrogen to protect the uterine lining. The form matters, and non-oral routes are generally preferred. Our *forms of hormone therapy* page covers the options.
Vaginal estrogen treats genitourinary symptoms directly, with minimal systemic absorption, alone or alongside systemic therapy. Many women who do not want systemic hormones do well on this by itself.
Testosterone declines gradually from a woman's twenties. The clearest documented effect is on sexual desire, and women also report better energy, mood and strength. There is no FDA-approved testosterone product for women in the United States, so it is prescribed off-label at female-appropriate doses and monitored with labs.
Non-hormonal options exist for women who cannot take hormones or prefer not to, including effective ones specifically for hot flashes.
And the rest of the picture. Thyroid disease overlaps almost completely with menopause in its symptoms and is the most common thing missed. Iron, vitamin D, B12 and metabolic markers all matter. Resistance training and adequate protein address the muscle loss behind the change in body composition.
The Women's Health series
This hub links down to each deep-dive in the cluster. Start anywhere.
the transition, why normal labs don't rule it out, and what to do before your periods stop.
what it does, what it protects, and where the risks actually come from.
the 2002 trial in its own numbers, and why its two arms gave opposite answers.
estrogen, progesterone, the delivery options, and what "bioidentical" means.
a primary female hormone, what it does, and how it is dosed.
why a result inside the reference range is not always an answer.
overlapping symptoms, treated together.
antibodies, what they mean, and what the evidence says about diet.
the metabolic side.
why it happens and what works.
Let's begin
An evaluation shows what is driving your symptoms and what your long-term picture looks like, bone and cardiovascular included. An unhurried hour with a Menopause Society Certified Practitioner, with comprehensive labs read alongside it. To speak with us first, call 714-671-2005.
Perimenopause: what's happening, and what helps
The benefits of hormone therapy
The forms of hormone therapy, and how treatment is personalized
Menopause weight gain: where GLP-1 medication and hormones fit
The average age in the United States is 52. Menopause between 40 and 45 is called early menopause. Before 40 it is premature ovarian insufficiency, which is a distinct diagnosis requiring its own workup.
Twelve consecutive months without a period, which means it is identified looking backward. There is no test that confirms it on the day, and hormone levels are not needed to make the diagnosis in a woman of typical age.
Hot flashes and night sweats usually improve over a period of years, sometimes many, and they persist longer on average in Black and Hispanic women.
Vaginal and urinary symptoms are the exception. They are progressive and do not resolve on their own.
Possibly. Hot flashes stopping does not mean the other changes have. Genitourinary symptoms progress, bone loss continues, and cardiovascular risk rises, all without symptoms in the early years.
The current term for what low estrogen does to vaginal and urinary tissue: dryness, thinning, discomfort with sex, urinary urgency and recurrent urinary infections. It is common, it is progressive without treatment, and it responds well to treatment including years after menopause.
For appropriate candidates it is, and for many women it is beneficial beyond symptom relief. The risks belong to specific hormones and specific routes rather than to hormones as a category, which our *benefits of hormone therapy* page sets out.
It depends on how long it has been and on your individual risk, and it is a conversation worth having rather than assuming the window has closed. Vaginal estrogen for genitourinary symptoms can be started at any point.
If your ovaries were removed, menopause began at that point and is usually more abrupt.
If your uterus was removed but your ovaries remain, you will go through menopause at the usual time without the marker of periods stopping, so it is identified on symptoms. Women without a uterus generally do not need progesterone alongside estrogen.
No, though body composition does change. Muscle declines and fat shifts toward the abdomen, often with little change in total weight. Our *menopause weight gain* page covers where hormone therapy, resistance training and GLP-1 medication each fit.
